Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
The Oncologist|October 30, 2025
Adjuvant treatment preferences in high-risk upper tract urothelial carcinoma: the perspective of Portuguese medical oncologistsGuilherme Vilhais, Mário Fontes-SousaCells|August 27, 2021
The Roadmap of RANKL/RANK Pathway in CancerSandra Casimiro, Guilherme Vilhais, Inês Gomes, et al.Frontiers in Oncology|May 10, 2024
Metastatic organotropism: a brief overviewMargarida Carrolo, João A I Miranda, Guilherme Vilhais, et al.Oncotarget|June 2, 2020
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancerInês Gomes, Bernardo P de Almeida, Sara Dâmaso, et al.Frontiers in Oncology|April 11, 2024
Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiotaGuilherme Vilhais, Diogo Alpuim Costa, Mário Fontes-Sousa, et al.Pageof 1